1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,920 | 5,300 | 21:36 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.01. | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | 283 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| 16.01. | Elekta gets FDA nod for AI-powered linear accelerator for radiology | 5 | MassDevice | ||
| 26.11.25 | Elekta AB reports Q2 results | 11 | Seeking Alpha | ||
| 26.11.25 | Elekta AB Non-GAAP EPS of SEK 0.64, revenue of SEK 4.07B; reaffirms FY outlook | 7 | Seeking Alpha | ||
| ELEKTA AB ADR Aktie jetzt für 0€ handeln | |||||
| 26.11.25 | Elekta AB: Second quarter, August-October 2025/26 | 384 | GlobeNewswire (Europe) | Second quarterIn constant exchange rates, net sales increased by 1 percent mainly driven by Europe. Reported sales in SEK decreased by 6 percent amounting to SEK 4,070 M (4,341).The book-to-bill ratio... ► Artikel lesen | |
| 06.11.25 | Elekta deepens presence in China with manufacturing and R&D assets | 9 | China Daily | ||
| 29.09.25 | Elekta AB: Study shows MRI-guided adaptive radiotherapy with Elekta Unity improves patient-reported urinary symptoms in men with prostate cancer | 411 | GlobeNewswire (Europe) | Data from an international registry confirms that tracking changes in prostate anatomy and adjusting radiation at each treatment session can lead to better long-term quality of life
SAN FRANCISCO -... ► Artikel lesen | |
| 25.09.25 | Elekta AB: Elekta marks two millionth patient treated with Leksell Gamma Knife radiosurgery | 227 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) today announces that more than two million patients worldwide have now received Leksell Gamma Knife® radiosurgery. The two millionth treatment was recently carried out... ► Artikel lesen | |
| 08.09.25 | Dividendenbekanntmachungen (08.09.2025) | 8.307 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
| 08.09.25 | Elekta Names Klara Eiritz Next CFO As Hägglöv Departs | 4 | RTTNews | ||
| 04.09.25 | Elekta AB: Report from the Annual General Meeting 2025 of Elekta | 421 | GlobeNewswire (Europe) | Elekta AB (publ) has held its Annual General Meeting on September 4, 2025. The statement at the Meeting from the President and CEO will be available on Elekta's website, www.elekta.com. Documents from... ► Artikel lesen | |
| 03.09.25 | UBS initiates Elekta at "sell," cites slowing radiotherapy market and 30% downside | 11 | Investing.com | ||
| 03.09.25 | UBS initiates Elekta stock with Sell rating, citing market headwinds | 1 | Investing.com | ||
| 28.08.25 | Elekta AB: Interim report, First quarter May-July 2025/26 | 484 | GlobeNewswire (Europe) | First quarterIn constant exchange rates, net sales increased by 3 percent driven by Europe. Reported sales in SEK decreased by 5 percent amounting to SEK 3,646 M (3,825).Book-to-bill ratio of 1.05 (1.10)... ► Artikel lesen | |
| 23.07.25 | Elekta AB: Elekta receives U.S. FDA 510(k) clearance for its Gamma Knife radiosurgery system to treat patients with refractory, drug-resistant mesial temporal lobe epilepsy | 388 | GlobeNewswire (Europe) | New indication expands treatment options for neurosurgeons managing complex epilepsy cases
ATLANTA - Elekta (EKTA-B.ST) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k)... ► Artikel lesen | |
| 09.06.25 | Elekta AB: Elekta appoints Jakob Just-Bomholt as new President and CEO | 511 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today the appointment by the Board of Directors of Jakob Just-Bomholt as its new President and Chief Executive Officer, effective September 1, 2025.
Jakob, a... ► Artikel lesen | |
| 28.05.25 | Elekta AB: Year-end report May-April 2024/25 | 523 | GlobeNewswire (Europe) | Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio... ► Artikel lesen | |
| 03.05.25 | Elekta AB: Clinical trial shows more precise radiotherapy using Elekta Unity MR-Linac preserves sexual function in men with prostate cancer | 370 | GlobeNewswire (Europe) | ERECT trial used MR-guidance to spare nerves and blood vessels essential for achieving and maintaining an erection
VIENNA - Elekta (EKTA-B.ST) today announced that use of its 1.5T Elekta Unity MR-Linac... ► Artikel lesen | |
| 07.03.25 | Dividendenbekanntmachungen (07.03.2025) | 19.341 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2177 EUR AEW UK REIT PLC GB00BWD24154 0,02 GBP EUR AMERISAFE INC US03071H1005 0... ► Artikel lesen | |
| 26.02.25 | Elekta AB: Gustaf Salford to leave position as President and CEO of Elekta as of March 6 | 545 | GlobeNewswire (Europe) | STOCKHOLM - Elekta (EKTA-B.ST) announced today that Gustaf Salford, President and CEO, and the Board of Directors, have decided that Gustaf will leave Elekta as of March 6. Jonas Bolander, Executive... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FAMICORD | 5,250 | -1,87 % | EQS-News: FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung | EQS-News: FamiCord AG
/ Schlagwort(e): 9-Monatszahlen
FamiCord AG beschleunigt profitables Wachstum im dritten Quartal 2025 und stärkt Qualität und Visibilität der Umsatzentwicklung... ► Artikel lesen | |
| SPINEWAY | 0,194 | +13,33 % | SPINEWAY: 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) | Ecully, January 13, 2026 - 6:30 p.m. SPINEWAY 2025 revenue of €12.4 million, with an acceleration of sales in Q4 2025 (+34%) In thousands of euros20252024Change as a %H1 revenue5,5736,535-15%H2... ► Artikel lesen | |
| PETMED EXPRESS | 2,628 | -1,72 % | Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways | MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing... ► Artikel lesen | |
| QUIDELORTHO | 19,000 | -4,52 % | QuidelOrtho Corporation: QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio | Agreement adds new analyzer platforms and expands assay menu across key international marketsSAN DIEGO, Feb. 16, 2026 /PRNewswire/ -- QuidelOrtho has entered a long-term strategic supply... ► Artikel lesen | |
| ELEKTA | 5,150 | -1,34 % | Elekta AB: Elekta presents Strategic Update: growth, innovation, and operations | STOCKHOLM - Elekta (EKTA-B.ST) today, at 14:00 CET, hosts its Strategic Update for investors, providing an overview of the company's strategic direction and ongoing transformation. The event, led by... ► Artikel lesen | |
| STAAR SURGICAL | 13,660 | +0,77 % | STAAR Surgical stock price target lowered to $19 by Stifel on China concerns | ||
| TELEFLEX | 89,00 | +1,71 % | Teleflex Incorporated: Teleflex Announces Leadership Transition | Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025... ► Artikel lesen | |
| NOVACYT | 0,413 | +1,10 % | Novacyt S.A. - Liquidity Agreement Monthly Update and TVR | ||
| M3 INC | 9,100 | +0,55 % | M3, Inc. Nine Months Income Climbs | TOKYO (dpa-AFX) - M3, Inc. (4YC.F) released a profit for its nine months that Increased, from the same period last yearThe company's earnings came in at JPY41.650 billion, or JPY61.39 per share.... ► Artikel lesen | |
| INSPIRE MEDICAL SYSTEMS | 51,18 | +1,59 % | Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results | Fourth quarter revenue growth of 12% and full year revenue growth of 14%Fourth quarter net income per diluted share of $4.66; adjusted net income per diluted share of $1.65Full year net income per... ► Artikel lesen | |
| AMBEA | 10,710 | -2,01 % | Ambea AB: Ambea Year-end Report January-December 2025 | Significant investments in future growth
CEO's statement:
In the last quarter of the year, we continued investing strongly in growth through acquisitions and new operations as well as through developing... ► Artikel lesen | |
| SHIP HEALTHCARE | 14,600 | -0,68 % | Ship Healthcare Holdings Inc Reveals Drop In Nine Months Profit | ||
| BUMRUNGRAD HOSPITAL | 5,100 | 0,00 % | Bumrungrad Launches "Smart Personalized HealthMatch" and "Biological Age" Revolutionizing Preventive Health Screening | ||
| SIEMENS HEALTHINEERS | 40,930 | +1,41 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat das Kursziel für Siemens Healthineers von 52,90 auf 52,15 Euro gesenkt, aber die Einstufung auf "Outperform" belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS | 51,12 | +1,47 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
09.02.2026 /... ► Artikel lesen |
ELEKTA AB ADR gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 5,350 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELEKTA AB ADR finden Sie auf Wallstreet Online.